Advanced Search


Study ID Status Title Patient Level Data
115470 Completed A Phase 4, Multi-Center, Randomized, Open-Label Study to Evaluate the Effect of BENLYSTA™ (belimumab; HGS1006) on Vaccine Responses in Subjects with Systemic Lupus Erythematosus (SLE) Study Listed on
115476 Completed Meta-Analysis of VRX-RET-E22-303 and VRX-RET-E22-304: Two Multicenter, Open-Label, Long-Term, Safety, Tolerability and Efficacy Studies of Retigabine in Adult Epilepsy Patients with Partial-onset Seizures (Extensions of Studies VRX-RET-E22-301 and VRX-RET-E22-302)
115478 Completed PGx 377: Pharmacogenetic evaluation of the association of functional variation in ADRB1 and ADRB2 genes with tolerability to carvedilol in the Phase I/II study CRV110734
115484 Completed A randomized, double blind, placebo controlled study to investigate the effect of donepezil and gabapentin combination on an experimental pain model in healthy subjects
115486 Completed Tolerability and safety of multiple dose regimens of TRX4 anti-CD3 monoclonal antibody in Type 1 Diabetes Mellitus
115487 Completed Randomized, double-blind, 5 period cross over study assessing lung function in healthy volunteers following single inhalations of GSK573719 Inhalation Powder from two configurations of the Novel Dry Powder Inhaler Study Listed on
115489 Completed Special Drug Use Investigation for Arixtra® (fondaparinux) Venous Thromboembolism Treatment
115490 Completed Special Drug Use Investigation (retrospective) for Arixtra® (fondaparinux) Venous Thromboembolism Treatment (over 100kg)
115493 Terminated TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD) Study Listed on
115494 Completed Durable-Response Therapy Evaluation For Early- or New-Onset Type 1 Diabetes Study Listed on
115495 Completed Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes - DEFEND Study Listed on
115496 Completed DEFEND-1 Long Term Follow Up: Durable-Response Therapy Evaluation for Early or New Onset Type 1 Diabetes Extension Study Study Listed on
115515 Completed An open-label single and repeat dose study to investigate the pharmacokinetic profiles of tenofovir disoproxil fumarate 300 mg in healthy Chinese subjects
115517 Completed A single/repeat dose study with three oral formulations of Firategrast (immediate release tablet, modified release tablet, and naso-gastric infusion) in healthy male volunteers
115519 Completed Double-Blind, Randomized, Placebo-Controlled Study to Assess Safety, Efficacy, and Pharmacokinetics (PK) of GSK2336805 in Combination With Peginterferon and Ribavirin in Treatment-naive Chronic Hepatitis C Subjects With Hepatitis C Virus Genotypes 1 or 4
115523 Completed Observer-blind study to evaluate efficacy, safety, and immunogenicity of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A
115524 Relinquished Immunogenicity and safety study of GSK Biologicals’ meningococcal vaccine GSK 134612 administered to at risk subjects from 1 to less than 18 years
115535 Completed A Randomized, Double Blind, Single Dose, Cross-Over Study to Assess the Cardiovascular Effects of GSK2336805 in Healthy Adult Volunteers
115550 Completed A Single Centre, 5-Period, Randomized Study To Evaluate The Relative Bioavailability Of An Immediate Release Tablet Formulation And Prototype Bioenhanced Formulations Of GSK1325756 In Healthy Elderly Subjects During Suppression Of Gastric Acid Secretion Study Listed on
115553 Completed PROACTYVE pilot:Pilot study of Patient’s adherence to TYKERB™/TYVERB™+capecitabine in metastatic breast cancer–observation of patient adherence and evaluation of predictive factors for patient adherence after providing educational programme
115555 Completed Immunogenicity and safety study of GlaxoSmithKline Biological's live attenuated measles mumps rubella varicella vaccine (PriorixTetra™) when co-administered with conjugated Meningococcal C vaccine (Meningitec®, Nuron Biotechs’ Vaccine) in healthy children
115563 Completed PGx418 Exploratory Pharmacogenetic Research on Efficacy of BENLYSTA (belimumab) in BEL110752 (BLISS-52) and BEL110751 (BLISS-76)
115570 Completed A Single Dose First in Human Study of GSK2398852 Co-Administered with GSK2315698 in Patients with Systemic Amyloidosis Study Listed on
115573 Terminated A repeat-dose, open-label, parallel-group study to assess the pharmacokinetics of GSK1278863 and metabolites in normal subjects and subjects with impaired renal function
115575 Completed MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects with Severe Refractory Asthma Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.